3//SEC Filing
HILLHOUSE INVESTMENT MANAGEMENT, LTD. 3
Accession 0000902664-24-000669
CIK 0001868279other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 9:01 PM ET
Size
8.1 KB
Accession
0000902664-24-000669
Insider Transaction Report
Form 3
Hillhouse Capital Management, Ltd.
10% Owner
Holdings
- (indirect: See footnotes)
Series B Preferred Stock
→ Common Stock (313,076 underlying) - (indirect: See footnotes)
Series A Preferred Stock
→ Common Stock (3,616,041 underlying)
Footnotes (4)
- [F1]The preferred stock is convertible into shares of common stock on a 15.21-for-1 basis, at the holder's election, and will automatically convert into shares of the Issuer's common stock upon the closing of the initial public offering pursuant to their terms. The preferred stock has no expiration date.
- [F2]The securities reported herein are held by VSUM VI Holdings Limited ("VSUM VI") and VSUM VIII Holdings Limited ("VSUM VIII"). VSUM VI is a wholly owned subsidiary of Hillhouse Venture Fund V, L.P. ("Hillhouse Venture V") and VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare Fund, L.P. ("Hillhouse Healthcare"). HIM (as defined below) acts as the sole management company of each of Hillhouse Venture V and Hillhouse Healthcare.
- [F3]The securities reported herein are held by VSUM VIII and ARVT Holdings Limited ("ARVT"). VSUM VIII is a wholly owned subsidiary of Hillhouse Healthcare and ARVT is a wholly owned subsidiary of Hillhouse Venture Fund VI, L.P. ("Hillhouse Venture VI"). HIM acts as the sole management company of each of Hillhouse Healthcare and Hillhouse Venture VI.
- [F4]This statement is filed by Hillhouse Investment Management, Ltd., an exempted Cayman Islands company ("HIM" or the "Reporting Person"). The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.
Documents
Issuer
ArriVent Biopharma, Inc.
CIK 0001868279
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001510589
Filing Metadata
- Form type
- 3
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 9:01 PM ET
- Size
- 8.1 KB